Annual FCF:
-$128.68M+$16.98M(+11.66%)Summary
- As of today, AXSM annual free cash flow is -$128.68 million, with the most recent change of +$16.98 million (+11.66%) on December 31, 2024.
- During the last 3 years, AXSM annual free cash flow has fallen by -$20.15 million (-18.56%).
- AXSM annual free cash flow is now -7789.15% below its all-time high of -$1.63 million, reached on December 31, 2013.
Performance
AXSM Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly FCF:
-$32.44M+$11.28M(+25.80%)Summary
- As of today, AXSM quarterly free cash flow is -$32.44 million, with the most recent change of +$11.28 million (+25.80%) on June 30, 2025.
- Over the past year, AXSM quarterly free cash flow has dropped by -$2.27 million (-7.54%).
- AXSM quarterly free cash flow is now -2674.44% below its all-time high of -$1.17 million, reached on March 31, 2015.
Performance
AXSM Quarterly Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM FCF:
-$121.10M-$2.27M(-1.91%)Summary
- As of today, AXSM TTM free cash flow is -$121.10 million, with the most recent change of -$2.27 million (-1.91%) on June 30, 2025.
- Over the past year, AXSM TTM free cash flow has increased by +$46.91 million (+27.92%).
- AXSM TTM free cash flow is now -10258.57% below its all-time high of -$1.17 million, reached on March 31, 2015.
Performance
AXSM TTM Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Free Cash Flow Formula
FCF = Cash From Operations − CAPEX
AXSM Free Cash Flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +11.7% | -7.5% | +27.9% |
| 3Y3 Years | -18.6% | +4.0% | +1.4% |
| 5Y5 Years | -177.4% | -71.7% | -60.4% |
AXSM Free Cash Flow Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -18.6% | +11.7% | -450.5% | +41.5% | -34.2% | +37.4% |
| 5Y | 5-Year | -177.4% | +11.7% | -450.5% | +41.5% | -60.4% | +37.4% |
| All-Time | All-Time | -7789.1% | +11.7% | -2674.4% | +41.5% | >-9999.0% | +37.4% |
AXSM Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | -$32.44M(+25.8%) | -$121.10M(-1.9%) |
| Mar 2025 | - | -$43.71M(-66.6%) | -$118.83M(+7.7%) |
| Dec 2024 | -$128.68M(+11.7%) | -$26.23M(-40.1%) | -$128.68M(+3.1%) |
| Sep 2024 | - | -$18.72M(+37.9%) | -$132.82M(+20.9%) |
| Jun 2024 | - | -$30.16M(+43.7%) | -$168.01M(+13.1%) |
| Mar 2024 | - | -$53.56M(-76.4%) | -$193.34M(-32.7%) |
| Dec 2023 | -$145.66M(-24.3%) | -$30.37M(+43.7%) | -$145.66M(-1.8%) |
| Sep 2023 | - | -$53.92M(+2.8%) | -$143.04M(-27.8%) |
| Jun 2023 | - | -$55.48M(-841.6%) | -$111.94M(-24.1%) |
| Mar 2023 | - | -$5.89M(+78.8%) | -$90.24M(+23.0%) |
| Dec 2022 | -$117.21M(-8.0%) | -$27.74M(-21.6%) | -$117.21M(+1.2%) |
| Sep 2022 | - | -$22.82M(+32.4%) | -$118.62M(+3.4%) |
| Jun 2022 | - | -$33.78M(-2.8%) | -$122.83M(-7.3%) |
| Mar 2022 | - | -$32.87M(-12.8%) | -$114.46M(-5.2%) |
| Dec 2021 | -$108.53M(-38.3%) | -$29.15M(-7.8%) | -$108.84M(-8.6%) |
| Sep 2021 | - | -$27.03M(-6.4%) | -$100.27M(-12.7%) |
| Jun 2021 | - | -$25.41M(+6.7%) | -$88.98M(-7.9%) |
| Mar 2021 | - | -$27.25M(-32.4%) | -$82.47M(-5.0%) |
| Dec 2020 | -$78.50M(-69.2%) | -$20.57M(-30.6%) | -$78.50M(-4.0%) |
| Sep 2020 | - | -$15.75M(+16.7%) | -$75.50M(-7.3%) |
| Jun 2020 | - | -$18.90M(+18.8%) | -$70.38M(-17.0%) |
| Mar 2020 | - | -$23.28M(-32.5%) | -$60.17M(-29.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2019 | -$46.39M(-54.2%) | -$17.57M(-65.3%) | -$46.39M(-20.1%) |
| Sep 2019 | - | -$10.63M(-22.3%) | -$38.62M(-13.9%) |
| Jun 2019 | - | -$8.69M(+8.5%) | -$33.91M(-3.1%) |
| Mar 2019 | - | -$9.50M(+3.0%) | -$32.89M(-9.3%) |
| Dec 2018 | -$30.09M(-13.6%) | -$9.79M(-65.4%) | -$30.09M(-13.2%) |
| Sep 2018 | - | -$5.92M(+22.9%) | -$26.58M(+2.0%) |
| Jun 2018 | - | -$7.68M(-14.7%) | -$27.11M(-2.2%) |
| Mar 2018 | - | -$6.70M(-6.4%) | -$26.54M(-0.2%) |
| Dec 2017 | -$26.48M(-23.8%) | -$6.29M(+2.5%) | -$26.48M(+3.4%) |
| Sep 2017 | - | -$6.45M(+9.1%) | -$27.41M(-6.1%) |
| Jun 2017 | - | -$7.10M(-6.9%) | -$25.84M(-7.4%) |
| Mar 2017 | - | -$6.64M(+8.1%) | -$24.07M(-12.5%) |
| Dec 2016 | -$21.39M(-186.7%) | -$7.22M(-48.0%) | -$21.39M(-30.3%) |
| Sep 2016 | - | -$4.88M(+8.4%) | -$16.42M(-21.9%) |
| Jun 2016 | - | -$5.33M(-34.6%) | -$13.47M(-31.4%) |
| Mar 2016 | - | -$3.96M(-75.5%) | -$10.25M(-37.4%) |
| Dec 2015 | -$7.46M(-62.3%) | -$2.25M(-17.0%) | -$7.46M(-43.3%) |
| Sep 2015 | - | -$1.93M(+8.6%) | -$5.20M(-58.8%) |
| Jun 2015 | - | -$2.11M(-80.3%) | -$3.28M(-180.3%) |
| Mar 2015 | - | -$1.17M | -$1.17M |
| Dec 2014 | -$4.60M(-181.8%) | - | - |
| Dec 2013 | -$1.63M | - | - |
FAQ
- What is Axsome Therapeutics, Inc. annual free cash flow?
- What is the all-time high annual free cash flow for Axsome Therapeutics, Inc.?
- What is Axsome Therapeutics, Inc. annual free cash flow year-on-year change?
- What is Axsome Therapeutics, Inc. quarterly free cash flow?
- What is the all-time high quarterly free cash flow for Axsome Therapeutics, Inc.?
- What is Axsome Therapeutics, Inc. quarterly free cash flow year-on-year change?
- What is Axsome Therapeutics, Inc. TTM free cash flow?
- What is the all-time high TTM free cash flow for Axsome Therapeutics, Inc.?
- What is Axsome Therapeutics, Inc. TTM free cash flow year-on-year change?
What is Axsome Therapeutics, Inc. annual free cash flow?
The current annual free cash flow of AXSM is -$128.68M
What is the all-time high annual free cash flow for Axsome Therapeutics, Inc.?
Axsome Therapeutics, Inc. all-time high annual free cash flow is -$1.63M
What is Axsome Therapeutics, Inc. annual free cash flow year-on-year change?
Over the past year, AXSM annual free cash flow has changed by +$16.98M (+11.66%)
What is Axsome Therapeutics, Inc. quarterly free cash flow?
The current quarterly free cash flow of AXSM is -$32.44M
What is the all-time high quarterly free cash flow for Axsome Therapeutics, Inc.?
Axsome Therapeutics, Inc. all-time high quarterly free cash flow is -$1.17M
What is Axsome Therapeutics, Inc. quarterly free cash flow year-on-year change?
Over the past year, AXSM quarterly free cash flow has changed by -$2.27M (-7.54%)
What is Axsome Therapeutics, Inc. TTM free cash flow?
The current TTM free cash flow of AXSM is -$121.10M
What is the all-time high TTM free cash flow for Axsome Therapeutics, Inc.?
Axsome Therapeutics, Inc. all-time high TTM free cash flow is -$1.17M
What is Axsome Therapeutics, Inc. TTM free cash flow year-on-year change?
Over the past year, AXSM TTM free cash flow has changed by +$46.91M (+27.92%)